• Home
• Reports
• Companies

• Partnering Search
• Pay-per-Click
• Profiling

• Out-licensing
• In-licensing
• Services

• PL Intelligence
• Deal Negotiation
• Deals review

• Press releases
• Events
• Newsletter

Latest updates

UTEK Pharmalicensing.com announces a new pricing model

Pharmalicensing, a division of UTEK Europe, is pleased to announce a new pricing model known as ‘Pay-per-Click'. Established to further expand listed opportunities and remove market barriers, this new model is effective from Jan 13th 2010.

The newly introduced Pay-per-Click pricing will create further market efficiencies for Pharmalicensing and will provide additional opportunities for buyers and sellers to access the platform, thereby creating a larger online IP marketplace.

"In 2009, we spent considerable effort listening to our clients on how we might serve the marketplace better. I believe this pricing change will further extend our lead and continue to make our marketplace the most efficient and highly trafficked online licensing platform in the pharmaceutical sector." Mark McBride, Managing Director of UTEK Pharmalicensing continues, "Our Pay-per-Click option is intended to remove pricing barriers for users of our service, increasing our base of potential clients. We continue to take as much risk as possible out of our clients' partner search process, and offer our visitors more opportunities to fill their drug pipelines."

All new clients will be eligible for the pricing structure, which will enable companies to post their profile and only pay for qualified traffic. Pay-per-Click clients will pay only for the partnering opportunities or potential partner click-throughs they receive. The Company plans to expand the new pricing model to its Medical Device Licensing platform as well as additional licensing platforms to be launched in 2010.

For more information please visit this page.

New collaboration presents big opportunities for UK SMEs

The recent signing of a co-promotional agreement between myM-link and Medical Device Licensing (a division of UTEK Europe, Ltd.), whereby myM-link will actively promote partnering opportunities from Medical Device Licensing's client companies directly to its member companies, is expected to present large-scale partnering opportunities to smaller companies operating in the UK life sciences market.

myM-link is a membership service for private companies in the life sciences market, which gives its members a competitive edge through networking, market intelligence and commercial opportunities.

Currently UTEK's Medical Device Licensing platform offers companies the opportunity to promote their device, diagnostic, delivery and equipment partnering and licensing opportunities on a global scale to the biggest names in the biopharmaceutical, life science and healthcare industries worldwide utilising the service to identify innovative IP and opportunities.

See the full release.

UTEK and Patents.com Form Partnership

Tampa, FL & Sterling, VA -- (Business Wire) - January 14, 2010 -- UTEK Corporation (NYSE Amex: UTK), a leading IP licensing and innovation services company, and Patents.com, one of the worlds most comprehensive sources of patent data, announce today a partnership, bringing their clients enhanced services.

In this new relationship, UTEK will provide in-licensing, out-licensing and analytics services to Patents.com's 50,000 plus registered users. The partnership will bring increased traffic to UTEK's online platforms and increased visibility for clients listing patents on those sites; ultimately driving more value realization from their IP assets.

"We're excited to be able to offer enhanced services and unique content to our communities. Our partnership with UTEK will make it easier for those who are seeking in and out-licensing opportunities to view the breadth and depth of what may be available to them," stated Paul Ratcliffe, Chief Executive Officer of Patents.com.

"We are pleased to have this relationship commence with the recent introduction of our new online pricing model. Through this partnership we will syndicate licensing data from our online platforms direct to the growing Patents.com community, and millions of new visitors will now be exposed to our unique content. We believe this increased, well-targeted traffic will drive market efficiencies and help our clients realize more value from their IP portfolios," commented Doug Schaedler, Chief Executive Officer of UTEK Corporation.

Through the partnership, UTEK will assume an Advisory role on the Patents.com Board of Directors as well as have a right of first refusal to acquire Patents.com over the next six-months.

For more information please visit:

www.patents.com or www.utekcorp.com

Generic molecules, OTC products and novel delivery technologies required for the Sub-Saharan African market.
Our client is a start up company that is looking for off patent generics indicated for oncology or respiratory disorders and innovative delivery platforms in which to incorporate them into. More

Method of preparing sustained release Trimetazidine Dihydrochloride composition for the treatment of angina.
Medium sized Indian company owns the patent for the preparation of sustained release Trimetazidine Dihydrochloride composition indicated for the treatment of angina and is now looking for out-licensing partners. More

Unique advanced herbal product indicated for the treatment of ischaemic heart condition, diabetes, diabetic lesions and circulatory diseases as well.
Our client has developed and tested a unique advanced herbal formulation capable of reverting ischaemic heart conditions and complications associated with diabetic foot; as well as re-establishing blood flow in circulatory pathologies. More

Our Products

Deal Negotiation

Pharmalicensing now offers expert support to assist and guide you through the entire deal negotiation process.

From the moment you select your partner, Pharmalicensing can help you with initial discussions, preparation of introductory material and suitable deal structure implementation, amongst other things.